Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dresner, S. C.
Right arrow Articles by Kennerdell, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dresner, S. C.
Right arrow Articles by Kennerdell, J. S.
NEUROLOGY 1985;35:1628
© 1985 American Academy of Neurology

Dysthyroid orbitopathy

Steven C. Dresner, MD and John S. Kennerdell, MD

From the University of Pittsburgh, Eye and Ear Hospital, Pittsburgh, PA.

Dysthyroid orbitopathy often presents with the classical signs and symptoms of hyperthyroidism with or without pretibial myxedema. However, it may start insidiously without a history of thyroid disease and without clinical signs of hyperthyroidism. The signs or symptoms may be confusing and mimic neurologic disease. The therapy of dysthyroid orbitopathy is becoming more accurately individualized, but is not yet directed at the immunologic cause.

Address correspondence and reprint requests to Dr. Kennerdell, Allegheny General Hospital, Dept of Ophthalmology, 320 East North Avenue, Pittsburgh, PA 15212.

Supported in part by a grant from The Research to Prevent Blindness, Inc.

Accepted for publication March 7, 1985.




This article has been cited by other articles:


Home page
Br J OphthalmolHome page
B. M Hosal, J. K Swanson, C. R Thompson, S. Kubota, K. Gunji, J. S Kennerdell, and J. R Wall
Significance of serum antibodies reactive with flavoprotein subunit of succinate dehydrogenase in thyroid associated orbitopathy
Br J Ophthalmol, May 1, 1999; 83(5): 605 - 608.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1985 by AAN Enterprises, Inc.